1Dotsika E,Karagouni E, Sundquist B, et al. Influence of Quillajasaponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus ISCOMs[J]. Scand J Immunol,1997,45:261-268.
2Sessler W G,Jung G.Synthetic lipopepitides as nvel adjuvants[J].Res Immunol,1992,143(5):548.
3Stede Y V,Verdonck F,Vancaenehhem S,et al.CpG-oligonucleotdesas an effective adjuvant in pigs for intromuscucular immunizations[J].Vet Immu and Immunopath,2002,86:31-41.
4O Haagan D T,Mackichan M L,Singh M.Recent development in adjuvants for vaccines agaist infectious diseases[J].BiomolecularEngineering,2001,18(3):69-85.
5Barr I G, Sjolander A,Cox J C. ISCOMs and other saponin based adjuvants[J].Advanced Drug Delivery Reviews,1998,32:247-271.
